Andy’s practice focuses on corporate and securities law. He represents numerous private and start-up technology and life sciences companies on matters ranging from incorporation and initial capitalization to venture capital financings, strategic transactions and board fiduciary duties. He also represents public companies in securities offerings, mergers and acquisitions, SEC reporting and corporate governance matters. In addition, he frequently represents investment banks in their underwriting transactions, and he also has broad transactional experience representing venture capital firms, private equity firms, family offices and corporate strategic investors in connection with their investments.